Aptimmune

Aptimmune

Aptimmune

Aptimmune Biologics specializes in the development and application of prophylactic measures against viral diseases of swine.
Type
B2b
Raised
$8.4M
Follow us
Alexa global traffic share
23 Jan 2018
$6,000,000
Venture capital (Series B)
24 Mar 2016
$2,420,000
Venture capital (Series A)

SEC FORM D/A

sec